BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
51.16
-0.02 (-0.04%)
At close: Aug 15, 2025, 11:35 AM
BridgeBio Pharma Fail-to-Deliver
Total FTD Shares
9.61K
Below Average
FTD / Avg. Volume
0.33%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
BridgeBio Pharma Inc. has
9,611
shares failed to deliver, representing 0.33%
of the average daily volume of
2,896,040
shares. Over the past year, the monthly average FTD is
36,517
shares, with the current level 74% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 47.69 | 9.61K | +2021.63% |
| Jun 30, 2025 | 43.18 | 453 | +1272.73% |
| May 22, 2025 | 32.97 | 33 | -98.81% |
| Apr 25, 2025 | 36.31 | 2.77K | +2672.00% |
| Mar 31, 2025 | 34.57 | 100 | -99.61% |
| Feb 26, 2025 | 33.45 | 25.35K | +1064.80% |
| Jan 29, 2025 | 36.46 | 2.18K | +5944.44% |
| Dec 31, 2024 | 27.44 | 36 | -90.06% |
| Nov 26, 2024 | 26.44 | 362 | +66.82% |
| Oct 16, 2024 | 26.34 | 217 | -65.99% |
| Sep 30, 2024 | 25.46 | 638 | -99.25% |
| Aug 30, 2024 | 27.85 | 85.62K | -75.47% |
| Jul 31, 2024 | 25.95 | 349.01K | +21077.73% |
| Jun 25, 2024 | 23.38 | 1.65K | -91.76% |
| May 21, 2024 | 29.28 | 20K | -63.65% |
| Apr 16, 2024 | 25.24 | 55.01K | +7244.73% |
| Mar 28, 2024 | 30.92 | 749 | +274.50% |
| Feb 29, 2024 | 34.15 | 200 | +36.99% |
| Jan 24, 2024 | 36.24 | 146 | -81.26% |
| Dec 28, 2023 | 41.81 | 779 | -88.54% |
| Nov 30, 2023 | 28.71 | 6.8K | +434.17% |
| Oct 27, 2023 | 24.44 | 1.27K | -74.00% |
| Sep 29, 2023 | 26.37 | 4.9K | +1915.23% |
| Aug 11, 2023 | 31.07 | 243 | +1004.55% |
| Jul 28, 2023 | 34.42 | 22 | -96.35% |
| Jun 30, 2023 | 17.2 | 602 | -74.72% |
| May 25, 2023 | 13.54 | 2.38K | +2007.08% |
| Apr 26, 2023 | 14.29 | 113 | -26.62% |
| Mar 31, 2023 | 16.58 | 154 | -90.43% |
| Feb 27, 2023 | 11.58 | 1.61K | +116.11% |
| Jan 31, 2023 | 9.28 | 745 | n/a |